The Step Up From Tamsulosin: What Comes Next When It Is Not Enough

Tamsulosin is where most men with prostate symptoms start, and for a good share of them it is not where the story ends. The stream improves, or it does not, and six months later something is still wrong. The question then is what the next step is, and the honest answer is that it depends entirely on which symptoms are left.

That sounds like a dodge. It is not. Alpha blockers like tamsulosin treat one half of the problem well and the other half barely at all, and which half you are left with decides everything that follows.

First work out which symptoms are left

Prostate symptoms split into two groups, and they have different causes.

Voiding symptoms are about getting urine out: a weak or hesitant stream, straining, stopping and starting, the feeling of not having emptied. These come from the obstruction itself, and they are what tamsulosin is built for. It relaxes the smooth muscle in the bladder neck and prostate, and the stream improves.

Storage symptoms are about what the bladder does between visits: urgency, going often, getting up at night. These are driven by the bladder muscle, which after years of pushing against an obstruction becomes overactive in its own right. Relaxing the prostate does not calm an irritable bladder, and this is the part men are most often left with.

So before anything changes, answer one question: is what bothers you the stream, or the urgency and the nights? The rest of this page follows from that answer.

If the problem is urgency and getting up at night

There is a trial that speaks directly to this, and its most interesting result is one that rarely gets quoted.

In 2006, JAMA published a study of 879 men who had both prostate symptoms and an overactive bladder, confirmed with a bladder diary: at least eight visits a day and at least three episodes of urgency. They were randomised to placebo, tolterodine (a bladder-calming drug), tamsulosin, or both, for twelve weeks.

After twelve weeks, the share of men who said they had benefited was 80% on the combination, against 62% on placebo. That difference was clear-cut.

Tamsulosin alone reached 71%, and that did not separate from placebo (p = 0.06). In a group of men selected for urgency and frequency, the alpha blocker on its own could not be distinguished from nothing. That is not a knock against tamsulosin. It is a statement about what it was designed to do, tested in men whose remaining problem was the other half.

On what men actually count, the combination moved things the alpha blocker had not: urgency episodes, visits per twenty-four hours, and visits per night all improved more than on placebo. A later review pooling seventeen trials of tamsulosin with solifenacin, another bladder drug, in nearly 3,800 men found the same pattern — better total and storage symptom scores and better quality of life than tamsulosin alone.

The caution attached to this is real and worth stating plainly. Calming a bladder that is working against an obstruction can in principle tip a man into retention. In the JAMA trial it was rare: acute retention needing a catheter happened in 0.4% on the combination, 0% on tamsulosin alone. Rare is not never, which is why a doctor will usually want to know how much urine you leave behind after voiding before adding one of these.

If the prostate itself is large

The other established step up is adding a 5-alpha reductase inhibitor, finasteride or dutasteride, which shrinks the gland over months rather than relaxing it over days. This is the route with the longest trial record, and it is the one that reduces the chance of ending up in retention or in an operating theatre.

It is also the route with the most trade-offs, including sexual side effects and a PSA reading that halves and has to be interpreted differently from then on. All of that is covered separately.

If erections are also a problem

Tadalafil at 5 mg a day treats prostate symptoms and erectile dysfunction with one tablet, and in a head-to-head placebo-controlled trial it improved symptoms slightly more than tamsulosin did. For a man who has both problems, this is the only option on this page that addresses both at once.

Switching to a different alpha blocker is mostly a side-effect decision

A network meta-analysis published in 2024 pooled 22 trials and 3,371 men across six alpha blockers and twelve dose categories. Tamsulosin 0.4 mg was among the strongest on symptom score, and no alpha blocker separated clearly from the others on flow rate.

The practical reading: if tamsulosin is not working, another drug in the same class is unlikely to work better simply by being different. Switching within the class makes sense when the problem is tolerability rather than effect — the ejaculatory side effect in particular, which is more pronounced with the more prostate-selective drugs. That is a reason to change. Hoping for more potency is not.

When the drugs have run out

There is a point at which adding a fourth tablet is not the answer, and it tends to arrive sooner than men expect. If symptoms are severe, if there is retention, repeated infections, blood in the urine or stones, the conversation moves to procedures — and the modern list is longer and gentler than the one most men picture. Several of them preserve ejaculation, which the older operation often does not.

This page cannot tell you which, and neither can any page. What it can tell you is that "the tablets are not working" is a reason to be referred, not a reason to add another tablet.

What to bring to the appointment

The trial above screened men with a bladder diary, and it is the single most useful thing you can turn up with. For three days, write down when you urinate, roughly how much, when urgency hits and when you drink.

It answers the fork at the top of this page better than any description from memory, and it turns "it is not really working" into something a doctor can act on in one visit rather than three.